<DOC>
	<DOCNO>NCT01046890</DOCNO>
	<brief_summary>The purpose clinical trial characterize drug interaction one medicinal herb widely use HIV infect patient : Echinacea sp . protease inhibitor darunavir/ritonavir .</brief_summary>
	<brief_title>Drug Interactions Between Echinacea Purpurea Darunavir/Ritonavir</brief_title>
	<detailed_description>15 patient antiretroviral therapy darunavir/ritonavir 600/100 mg twice day four week recruit . The patient receive treatment Echinacea purpurea 14 day , 500 mg every 6 hour . A 12 hour pharmacokinetic curve obtain baseline day 14 .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Darunavir</mesh_term>
	<criteria>1 . Patients infected HIV1 ( least one document positive WesternBlot ) . 2 . Age =/+ 18 year . 3 . Patients receive antiretroviral therapy contain darunavir / ritonavir approve dose 600/100 mg twice daily least 4 week 4 . HIV viral load plasma &lt; 50 copy / mL 5 . Absence acute infection / tumor three month prior inclusion . 6 . Subject able follow treatment period , without suspicion poor adherence previous antiretroviral treatment . 7 . Voluntary write informed consent . 1 . Any clinical historical observation could interfere pharmacokinetics medication , gastrointestinal illness surgery ( except herniotomy appendectomy ) , change composition plasma protein , indication hepatic renal dysfunction . 2 . Active alcohol consumption ( &gt; 50 g / day ) illicit drug ( except cannabis ) . 3 . Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Darunavir</keyword>
	<keyword>Echinacea purpurea</keyword>
	<keyword>Interaction</keyword>
	<keyword>Complementary Therapies</keyword>
</DOC>